Balentine LLC Catalent, Inc. Transaction History

Balentine LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $206,842 - $338,031	4,552 New	4,552 $299,000
Q2 2022 Oct 26, 2022	SELL	$87.2 - $114.05 $22,846 - $29,881	-262 Reduced 11.84%	1,950 $209,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $170,040 - $222,397	1,950 New	1,950 $209,000
Q1 2022 Oct 26, 2022	BUY	$94.19 - $124.49 $24,677 - $32,616	262 Added 13.44%	2,212 $245,000
Q3 2020 Nov 02, 2020	SELL	$72.74 - $92.5 $1,963 - $2,497	-27 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $1,296 - $2,134	27 New	27 $2,000
Q3 2019 Nov 15, 2019	SELL	$47.45 - $58.05 $1,898 - $2,322	-40 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $1,570 - $2,168	40 New	40 $2,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.